Common genetic risk factors for psychiatric and somatic disorders

Dialogues in Clinical Neuroscience

Volumn 5, Issue 2, 2003, Pages 129-138

  Bondy, Brigitta ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cardiovascular disorder; Fibromyalgia; Gene; Migraine; Polymorphism; Psychiatric disorder

Indexed keywords

AUTACOID; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; NEUROTRANSMITTER; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

CARDIOVASCULAR DISEASE; CATECHOLAMINERGIC SYSTEM; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; DRUG DEVELOPMENT; ENVIRONMENTAL FACTOR; FIBROMYALGIA; GENE FUNCTION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; IMMUNE SYSTEM; MENTAL DISEASE; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; PSYCHOSOMATIC DISORDER; REVIEW; RISK FACTOR; SEROTONINERGIC SYSTEM; TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0042671476     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Neeleman J, Ormel J, Bijl RV. The distribution of psychiatric and somatic ill health: associations with personality and socioeconomic status. Psychosom Med. 2001;63:239-247.
2. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Arch Gen Psychiatry. 1993;50:952-960.
3. Fava M. Somatic symptoms, depression, and antidepressant treatment. J Clin Psychiatry. 2002;63:305-307.
4. Vanitallie TB. Stress: a risk factor for serious illness. Metabolism. 2002;51:40-45.
5. Troxler RG, Sprague EA, Albanese RA, Fuchs R, Thompson AJ. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis. 1977;26:151-162.
6. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1-35.
7. Hahn MK, Blakely RD. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J. 2002;2:217-235.
8. Clarke BL, Moore DR, Blalock JE. Adrenocorticotropic hormone stimulates a transient calcium uptake in rat lymphocytes. Endocrinology. 1994;135:1780-1786.
9. Brebner K, Hayley S, Zacharko R, Merali Z, Anisman H. Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology. 2000;22:566-580.
10. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:11-38.
11. Muller N, Riedel M, Gruber R, Ackenheil M, Schwarz MJ. The immune system and schizophrenia. An integrative view. Ann N Y Acad Sci. 2000;917:456-467.
12. Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev. 2000;31:193-199.
13. Colomb M. Psychiatric symptoms in metabolic and other genetic disorders: is our organic workup complete.? Harvard Rev Psychiatry. 2002;10:242-248.
14. Ferrari MD. Migraine. Lancet 1998;351:9108-9151.
15. Sjostrand C, Giedratis V, Ekbom K, Waldenlind E, Hillert J. CACNA1A gene polymorphisms in cluster headache. Cephalalgia. 2001;21:10-18.
16. Guillem E, Pelissolo A, Lepine JP. Troubles mentaux et migraine: données epidemiologiques [in French]. Encephale. 1999;25:436-442.
17. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: is the association specific to migraine? Neurology. 2000;54:308-313.
18. 1A receptor-effector system responsivity in panic disorder. Psychopharmacol Berl. 1992;106:111-117.
19. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66:2621-2624.
20. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region [see comments]. Science. 1996;274:1527-1531.
21. Collier DA, Stober G, Li T, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders [see comments]. Mol Psychiatry. 1996;1:453-460.
22. Bondy B, Erfurth A, de Jonge S, Kruger M, Meyer H. Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol Psychiatry. 2000;5:193-195.
23. Yilmaz M, Erdal ME, Herken H, Cataloluk O, Barlas O, Bayazit YA. Significance of serotonin transporter gene polymorphism in migraine. J Neurol Sci. 2001;186:27-30.
24. Ogilvie AD, Russell MB, Dhall P, et al. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia. 1998;18:23-26.
25. 2C receptor gene and migraine. Neuroreport. 1997;8:2651-2653.
26. 2A receptor binding. Neuropsychopharmacology. 1997;16:211-216.
27. 2A receptor gene [see comments]. Lancet. 1995;346:281-282.
28. 2A receptor gene with aura in migraine. J Neurol Sci. 2001;188:99-101.
29. 2A) receptor gene. Cephalalgia. 1996;16:463-467.
30. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia. 2001;21:549-557.
31. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res. 2000;79:11-19.
32. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum. 1995;38:221-228.
33. Grimaldi LM, Casadei VM, Ferri C, et al. Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism. Ann Neurol. 2000;47:361-365.
34. Rainero I, Pinessi L, Salani G, et al. A polymorphism in the interleukin-1α gene influences the clinical features of migraine. Headache. 2002;42:337-340.
35. Trabace S, Brioli G, Lulli P, et al. Tumor necrosis factor gene polymorphism in migraine. Headache. 2002;42:341-345.
36. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee [see comments]. Arthritis Rheum. 1990;33:160-172.
37. Hudson JI, Pope HG. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol. 1994;8:839-856.
38. Ward NG, Bloom VL, Dworkin S, Fawcett J, Narasimhachari N, Friedel RO. Psychobiological markers in coexisting pain and depression: toward a unified theory. J Clin Psychiatry. 1982;43:32-41.
39. van Praag HM, Asnis GM, Kahn RS, et al. Monoamines and abnormal behaviour. A multi-aminergic perspective. Br J Psychiatry. 1990;157:723-734.
40. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol. 1997;24:555-559.
41. Almay BG, Von KL, Oreland L. Platelet MAO in patients with idiopathic pain disorders. J Neural Transm. 1987;69:243-253.
42. Juhl JH. Fibromyalgia and the serotonin pathway. Altern Med Rev. 1998;3:367-375.
43. Schwarz MJ, Spaeth M, Müller-Bardorff H, Pongratz DE, Bondy B, Ackenheil M. Relationship of substance P, 5-hydroxyindolic acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett. 1999;259:196-198.
44. Offenbaecher M, Bondy B, De JS, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42:2482-2488.
45. Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum. 2002;46:845-847.
46. 2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain. 1998;76:349-355.
47. 6 with neuropeptides in rat striatum. J Comp Neurol. 1996;370:405-414.
48. Almay BG, Johansson F, Von Knorring L, Le Greves P, Terenius L. Substance P in CSF of patients with chronic pain syndromes. Pain. 1988;33:3-9.
49. 2A receptor gene in fibromyalgia. Neurobiol Dis. 1999;6:433-439.
50. 2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int. 2001;21:58-61.
51. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580-592.
52. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 1993;270:1819-1825.
53. Carney RM, Freedland KE, Veith RC, et al. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry. 1999;45:458-463.
54. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995;332:1553-1559.
55. del Zoppo GJ. The role of platelets in ischemic stroke. Neurology. 1998;51(suppl 3):S9-S14.
56. Whyte EM, Pollock BG, Wagner WR, et al. Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry. 2001;158:2074-2076.
57. Williams RB, Marchuk DA, Gadde KM, et al. Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med. 2001;63:300-305.
58. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry. 1997;54:597-606.
59. Siffert W, Rosskopf D, Siffert G, et al. Association of a human G-protein beta3 subunit variant with hypertension [see comments]. Nat Genet. 1998;18:45-48.
60. Siffert W, Naber C, Walla M, Ritz E. G protein beta3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens. 1999;17:1095-1098.
61. Zill P, Baghai TC, Zwanzger P, et al. Evidence for an association between a G protein β3-gene variant with depression and response to antidepressant treatment. Neuroreport. 2000;11:1893-1897.
62. Bondy B, Baghai TC, Zill P, et al. Combined action of the ACE D- and G-protein β3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry. 2002;7:1120-1126.
63. Aguilera G, Kiss A, Luo X. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol. 1995;7:775-783.
64. Jenkins TA, Mendelsohn-Frederick AO, Chai SY. Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J Neurochem. 1997;68:1304-1311.
65. Kramer MS, Cutler N, Feighner J, et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors [see comments]. Science. 1998;281:1640-1645.
66. Gunduz H, Georges JL, Fleishman S. Quinapril and depression. Am J Psychiatry. 1999;156:1114-1115.
67. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
68. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
69. Corvol P, Soubrier F, Jeunemaitre X. Molecular genetics of the reninangiotensin-aldosterone system in human hypertension. Pathol Biol (Paris). 1997;45:229-239.
70. Arinami T, Li L, Mitsushio H, Itokawa M, Hamaguchi H, Toru M. An insertion/deletion polymorphism in the angiotensin-converting enzyme gene is associated with both brain substance P contents and affective disorders. Biol Psychiatry. 1996;40:1122-1127.
71. O'Malley JP, Maslen CL, Illingworth DR. Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia. Circulation. 1998;97:1780-1783.
72. Naber CK, Husing J, Wolfhard U, Erbel R, Siffert W, Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension. 2000;36:986-989.
73. Baghai T, Schüle C, Zwanzger P, et al. Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders. Mol Psychiatry. 2001;6:258-259.